The stock (CODX) has manifested an immediate reversal in direction within the early bell. Even though the PR had presented valuable insight on "High-Performance Detection of Cancer Mutation in Liquid Biopsy Samples" (TD Ameritrade). Be diligent as there could be a very quick and sporadic movement to the upside (bounce - bullish). Await confirmation prior to entering the market.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.